Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Video
All Video TypesAJMC TVGuidelinesInsightsOnLocationPayer PerspectivesPeer ExchangePost Conference PerspectivesShortsStakeholder Summit
Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
More
Conferences
Conference CoverageConference ListingPost Conference Perspectives
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Video
  • Podcasts
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Measuring Persistency with Drug Therapy in Glaucoma Management

Measuring Patient Persistency with Drug Therapy Using Methods for the Design and Analysis of Natural History Studies

ByEric S. Johnson, PhD,Essy Mozaffari, PharmD, MPH
August 1st 2002

Participating Faculty

By
August 1st 2002

Introduction

ByGail F. Schwartz, MD
August 1st 2002

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

ByWilliam C. Stewart, MD,Jessica Leech, BS,Elizabeth D. Sharpe, MD,John Kulze, MD,John Ellyn, MD,Douglas G. Day, MD
August 1st 2002

Population-Based Persistency Rates for Topical Glaucoma Medications Measured with Pharmacy Claims Data

BySamaresh Dasgupta, MHS,Vikki Oates, MAS,Brahim K. Bookhart, MBA,Baze Vaziri, MBA, CPA,Gail F. Schwartz, MD,Essy Mozaffari, PharmD, MPH
August 1st 2002

Rates of Discontinuation and Change of Glaucoma Therapy in a Managed Care Setting

ByJoshua J. Spooner, PharmD,Michael F. Bullano, PharmD,Laurence I. Ikeda, MD,Tara R. Cockerham, PharmD,William J. Waugh, PharmD,Thomas Johnson, Pha
August 1st 2002

Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population

ByFadia T. Shaya, PhD, MPH,C. Daniel Mullins, PhD,Winston Wong, PharmD,Jeannie Cho, PharmD
August 1st 2002

Measuring Persistency and Intraocular Pressure-Controlled Days in Patients Receiving Topical Glaucoma Medications

ByGail F. Schwartz, MD,Robert Platt, PhD
August 1st 2002
Advertisement
Advertisement

Trending on AJMC

1

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

2

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

3

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis

4

Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes

5

Childhood Influenza Vaccine Rates Decreased From 2017 to 2023

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text